Cancer cell adaptation to chemotherapy

Tumor resistance to chemotherapy may be present at the beginning of treatment, develop during treatment, or become apparent on re-treatment of the patient. The mechanisms involved are usually inferred from experiments with cell lines, as studies in tumor-derived cells are difficult. Studies of human...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC cancer Jg. 5; H. 1; S. 78
Hauptverfasser:	Di Nicolantonio, Federica, Mercer, Stuart J, Knight, Louise A, Gabriel, Francis G, Whitehouse, Pauline A, Sharma, Sanjay, Fernando, Augusta, Glaysher, Sharon, Di Palma, Silvana, Johnson, Penny, Somers, Shaw S, Toh, Simon, Higgins, Bernie, Lamont, Alan, Gulliford, Tim, Hurren, Jeremy, Yiangou, Constantinos, Cree, Ian A
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England BioMed Central 18.07.2005 BMC
Schlagworte:	Antineoplastic Agents - pharmacology ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism Biopsy Camptothecin - analogs & derivatives Camptothecin - pharmacology Cell Line, Tumor Cisplatin - pharmacology Down-Regulation Doxorubicin - pharmacology Drug Resistance, Neoplasm Drug Therapy - methods Epirubicin - pharmacology Fluorouracil - pharmacology Gene Expression Regulation, Neoplastic Humans Immunohistochemistry Neoplasms - drug therapy Paclitaxel - pharmacology Recurrence Reverse Transcriptase Polymerase Chain Reaction Time Factors Topotecan - pharmacology Treatment Outcome Up-Regulation
ISSN:	1471-2407, 1471-2407
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!